TEZNY 16.03   +0.080 +0.50% Updated: 05-06-2017 $TEZNY

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
10
TEZNY 16.03   +0.080 +0.50% Updated: 05-06-2017 $TEZNY
Last Trade: 5/5/2017 3:54:00 PM
Last 16.03   +0.080 +0.50%
Open 15.85
Previous Close 15.95
Day High / Low 16.03 / 15.85
Year High / Low - / -
Volume 9,573
Projected Volume 9573 (85%)
# of Trades / Projected 25 / 25
Dividend / Yield - / -
Abnormal Activity NONE
Abnormal Volume NO
Gap NONE
Candle BULLISH
Volatility Today HIGH
Volatility Yesterday HIGH
Price Relativity
From 40 Day High 101%
From 80 Day High 101%
From 150 Day High 101%
From 40 Day Low 115%
From 80 Day Low 124%
From 150 Day Low 130%
Pivot Analysis
Price Pivot $ 15.97
Day Resistance 1 $ 16.09
Day Support 1 $ 15.91
Day Resistance 2 $ 16.15
Day Support 2 $ 15.79
Consolidations
Short Term NO
Medium Term NO
Long Term YES
Volume Indicators
20 Day Avg Vol 11,239
Today / 20 Day Avg Vol BELOW
150 Day Avg Vol 33,652
Today / 150 Day Avg Vol BELOW
Abnormal Volume NO
William Volume Accumulation bullish
Volume Price Trend bullish
Momentum Indicators
10 Day Trend bullish
40 Day Trend bullish
100 Day Trend bullish
Stochastics neutral
RSI neutral
MACD bullish
Moving Average Indictors
15 Day Trend bullish
45 Day Trend bullish
100 Day Trend bullish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? NONE
Volatility Index Today HIGH
Volatility Index Yesterday HIGH
10 Day Volatility INCREASING
20 Day Volatility INCREASING
40 Day Volatility DECREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quest Diagnostics Faces Class Action After Data Breach

Updated Category News Views 4

Data Breach Rocks Quest Diagnostics October 2026 caught Quest Diagnostics in a bind they wish they could escape—a classic tech breach with personal info hanging out to dry. When a cyber ghost slipped into Quest's Quanum Lab Services Manager, it wasn't to deliver flowers. Nope, this unauthorized access was no friendly visit, forcing Quest to scream foul and play serious...

Continue Reading
FP Movement Opens Energizing Boutique in Cranston, RI

Updated Category News Views 23

FP Movement Expands with Style in Rhode Island FP Movement is shaking things up in Cranston, Rhode Island, bringing its signature activewear vibe to Garden City Center with a new shop. It’s not just about buying leggings anymore; it’s about diving into a lifestyle that screams energy and community spirit. The store, which spans 1,209 selling-square-feet, opened its...

Continue Reading
PZZA Faces Class Action: Strategic Shake-up or Misstep?

Updated Category News Views 3

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Continue Reading
Podcast Giants Converge in Tennessee for POD U Summit

Updated Category News Views 42

Nashville Becomes a Hotspot for Podcasters Amidst the strumming guitars and honky-tonk vibes of Nashville, Tennessee transformed into the epicenter of podcasting innovation thanks to Rebel Audio's inaugural summit, POD U. Here we had big names like Mike 'Big Mike' Majlak rubbing shoulders with sports experts and media moguls—a true concoction of voices shaping the...

Continue Reading
Zoomlion's Tower Cranes: Engineering Feats at Great Heights

Updated Category News Views 5

Pushing Boundaries with Towering Achievements When you're looking up at an engineering marvel, there's a good chance mighty cranes had their heyday lifting those towering ambitions. Zoomlion Heavy Industry Science & Technology Co., Ltd. just pulled a power move at the Lugu Lake Grand Bridge's 283-meter Shangri-La-side main tower. Picture that: two R4300-200 bad boys...

Continue Reading
Beta Bionics Faces Class Action Lawsuit Amid FDA Concerns

Updated Category News Views 59

Beta Bionics in the Legal Crosshairs When a company like Beta Bionics gets hauled into court, you know it's not just smoky mirrors and boardroom politics. The stakes are high right now, with investors lining up for a class-action lawsuit that zeroes in on a nasty bundle of allegations. This isn't just a blip on the radar. It's a seismic wave in the industry. Allegations...

Continue Reading
Howard Hughes Joins S&P SmallCap 600, Arcosa Out

Updated Category News Views 25

Shakeup in the S&P SmallCap 600 It’s one of those days where something shifts in the market landscape—Howard Hughes Holdings Inc. (NYSE: HHH) is swaggering into the S&P SmallCap 600. Kicking off on October 28, it's got quite the entrance lined up. On the other end, Arcosa Inc. (NYSE: ACA) is making a hasty exit after getting scooped up by CRH plc (NYSE: CRH). For...

Continue Reading
Divorce Expertise: Obenhaus Adds CDFA Credential

Updated Category News Views 21

Divorce isn't just a legal tangled mess; it's a financial minefield as well. Lindsey Obenhaus from Goranson Bain Ausley has beefed up her credentials with a Certified Divorce Financial Analyst® (CDFA®) designation, lending a sharper edge to her approach in divorce financials. When relationships turn sour, so do wallets, and Obenhaus aims to soften that blow for her...

Continue Reading
HYXI Eyes European Growth with Product Matrix Launch

Updated Category News Views 26

Unveiling the Future: HYXI's Grand Showcase You know you're onto something big when nearly 60 industry insiders travel halfway across the globe to see what you've got cooking. That's exactly what went down at HYXI's Hangzhou headquarters on October 21, 2026. Under a snazzy theme, "See Where It Begins, Shape the Future," this European Partner Day was more than just a...

Continue Reading
Hansa's Idefirix Shows Promise for Kidney Transplants

Updated Category News Views 11

Compelling Progress from Hansa Biopharma Y'know, navigating through the biotech jungle isn't for the faint-hearted. Hansa Biopharma's recent results with Idefirix could just be the beacon of hope for patients struggling on transplant lists. Announced at the ASN Kidney Week—a name that's got weight, by the way—these findings aren't just filling space. They're promising...

Continue Reading

Top 5 Most Recently Viewed Articles

Rubico Inc. Secures Time Charter Extensions to Enhance Revenue

Updated Category News Views 140

Rubico Inc. Expands Financial Outlook with Charter Extensions Rubico Inc. has made headlines recently as it announces the extension of time charters for both of its modern tanker vessels, supporting its steady growth in the shipping industry. Known for its eco-friendly, fuel-efficient tanker vessels, this move reflects the company's commitment to optimizing its...

Continue Reading
Exploring High-Yield Dividend Stocks in the Industrials Sector

Updated Category News Views 187

Investing in Dividend-Yielding Stocks During turbulent times in the financial markets, investors often seek refuge in dividend-yielding stocks. These stocks are typically from companies with strong free cash flows that reward their shareholders. In particular, high-yield dividend stocks can be an attractive option for those looking to generate income from their...

Continue Reading
Foventa Therapeutics: Spotlight on Diabetic Eye Treatment

Updated Category News Views 25

Foventa's Shift: From Science to Clinical Focus Well, isn't this a twist of fate? Exonate, the company that once thrived on cutting-edge science, is shedding its old skin and stepping into a new spotlight as Foventa Therapeutics. The old moniker is in the rearview, and now they're pledging to tackle non-proliferative diabetic retinopathy (NPDR) with a fresh angle—a...

Continue Reading
Elevating Patient Care: Viz.ai and Illuminate Unite Forces

Updated Category News Views 180

Innovative Partnership Between Viz.ai and Illuminate In a significant stride for patient care, Viz.ai has announced a collaborative expansion with Illuminate, a company renowned for its advancements in AI and natural language processing. This partnership aims to revolutionize the identification and monitoring of patients with cerebral aneurysms, facilitating timely...

Continue Reading
Trilogy Metals Shares Fiscal Insights and Project Developments

Updated Category News Views 328

Trilogy Metals Shares Fiscal Insights and Project Developments Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ), a notable player in metal exploration, recently announced its financial results for the third quarter ending August 31, 2025. The latest updates detail the company's fiscal health, progressive projects, and future outlook, revealing a net loss of $1.7...

Continue Reading